Bioventures Iii Gmbh & Co. Beteiligungs Kg Mpm is 10% at Somaxon Pharmaceuticals, Inc. (SOMX). They have made 4 open-market trades across 4 companies since 2007, most recently 2013-02-05.
CIK 0001249133
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $8.0M since 2007, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZLCS | SELL | 2011-10-07 | 2011-10-11 | $1.03 | $523K | N/A | N/A | N/A |
| VRUS | SELL | 2008-02-07 | 2008-02-11 | $22.55 | $549K | N/A | N/A | N/A |
| ETRM | BUY | 2007-11-20 | 2007-11-21 | $8.00 | $5.0M | -43.0% | -11.4% | -11.4% |
| ARYX | BUY | 2007-11-13 | 2007-11-13 | $10.00 | $3.0M | N/A | N/A | N/A |
| SOMX | SELL · 10b5-1 | 2007-05-08 | 2007-05-10 | $18.23 | $1.3M | N/A | N/A | N/A |
| SOMX | SELL · 10b5-1 | 2007-05-01 | 2007-05-03 | $18.07 | $589K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Shares reported on the most recent Form 4, priced at the 2013-02-07 close. 6 holdings could not be priced and are excluded from the total.